Bioxcel Therapeutics, Inc.
SEC CIK 1720893 · BTAI ] · last insider filing 2026-06-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mehta Vimal | Director · CEO, President, Secretary | filed 2018 - 2026 |
| Miller Michael Patrick | Director | filed 2022 - 2026 |
| Mueller Peter | Director | filed 2018 - 2026 |
| Patni Rajiv | Director | filed 2025 - 2026 |
| Votruba Michal | Director | filed 2019 - 2026 |
| Mack David J. | Director | filed 2024 - 2026 |
| Laumas Sandeep | Director | filed 2018 - 2026 |
| Bray June | Director | filed 2021 - 2026 |
| Nandabalan Krishnan | Director | filed 2018 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Steinhart Richard I | Senior VP and CFO | filed 2018 - 2026 |
| Yocca Frank | Chief Scientific Officer | filed 2018 - 2026 |
| Rodriguez Javier | See Remarks | filed 2021 - 2026 |
| O'Neill Vincent | See Remarks | filed 2018 - 2025 |
| Wiley Matthew T. | Chief Commercial Officer | filed 2022 - 2025 |
| Kane William P Jr | Chief Commercial Officer | filed 2020 - 2021 |
| Benabou Reina | See Remarks | filed 2020 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.